Robert Goulart to Practice Guidelines as Topic
This is a "connection" page, showing publications Robert Goulart has written about Practice Guidelines as Topic.
Connection Strength
0.452
-
Goulart RA, Nayar R, Lorey T, Joste N, Stoler MH. Extended HPV genotyping and dual stain for the triage of primary HPV screen-positive cases: Practical guidance for the cytopathology laboratory. Cancer Cytopathol. 2025 Apr; 133(4):e70006.
Score: 0.171
-
Davey DD, Goulart R, Nayar R. Update on HPV test utilization. Am J Clin Pathol. 2014 May; 141(5):759.
Score: 0.080
-
Davis Davey D, Davey DD, Goulart R, Nayar R. 2013 statement on human papillomavirus test utilization [corrected]. Diagn Cytopathol. 2014 May; 42(5):449-52.
Score: 0.080
-
Davey DD, Goulart R, Nayar R. 2013 statement on human papillomavirus DNA test utilization. Am J Clin Pathol. 2014 Apr; 141(4):459-61.
Score: 0.080
-
Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. J Low Genit Tract Dis. 2015 Apr; 19(2):91-6.
Score: 0.021
-
Davis Davey D, Goulart R, Nayar R. 2013 statement on human papillomavirus [corrected] test utilization. Acta Cytol. 2014; 58(2):113-6.
Score: 0.020